APO Research
Talk to an analyst

APO RESEARCH · REPORT

Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Industry Growth and Trends Forecast to 2032

20 December 202599 pages

Choose your research edition.

Industry ResearchAge Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Industry Research Report 2026117 pages · $2,950 USDIndustry Growth & TrendsGlobal Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Industry Growth and Trends Forecast to 203299 pages · $3,450 USDMarket StructureGlobal Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032182 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs include Novartis, Roche, Bayer Healthcare, Regeneron Pharmaceuticals, Neurotech Pharmaceuticals and Allergan, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs market size, estimates, and forecasts are presented in terms of sales volume (W Tons) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market by Company

Novartis

Roche

Bayer Healthcare

Regeneron Pharmaceuticals

Neurotech Pharmaceuticals

Allergan

Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Segment by Type

Macular Degeneration Drugs

Diabetic Retinopathy Drugs

Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Segment by Application

50-60 Years Old

60-70 Years Old

Others

Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Macular Degeneration Drugs Table 2. Major Company of Diabetic Retinopathy Drugs Table 3. Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales by Type (2021-2026) & (W Tons) Table 5. Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales Market Share in Volume by Type (2021-2026) Table 6. Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales by Type (2021-2026) & (US$ Million) Table 7. Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales Market Share in Value by Type (2021-2026) Table 8. Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Price by Type (2021-2026) & (US$/Ton) Table 9. Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales by Type (2027-2032) & (W Tons) Table 10. Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales Market Share in Volume by Type (2027-2032) Table 11. Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales by Type (2027-2032) & (US$ Million) Table 12. Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales Market Share in Value by Type (2027-2032) Table 13. Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Price by Type (2027-2032) & (US$/Ton) Table 14. North America Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales by Type (2021-2026) & (W Tons) Table 15. North America Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales by Type (2021-2026) & (W Tons) Table 17. Europe Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales by Type (2021-2026) & (W Tons) Table 19. Asia-Pacific Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales by Type (2021-2026) & (W Tons) Table 21. Latin America Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales by Type (2021-2026) & (W Tons) Table 23. Middle East and Africa Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales by Type (2021-2026) & (US$ Million) Table 24. Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Industry Trends Table 25. Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Industry Drivers Table 26. Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Industry Opportunities and Challenges Table 27. Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Industry Restraints Table 28. Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Revenue Market Share by Company (2021-2026) Table 30. Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales by Company (2021-2026) & (W Tons) Table 31. Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales Share by Company (2021-2026) Table 32. Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Price by Company (2021-2026) & (US$/Ton) Table 33. Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Major Company Production Sites and Headquarters Table 35. Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Company, Product Type & Application Table 36. Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales by Region (2021-2026) & (W Tons) Table 41. Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales Market Share in Volume by Region (2021-2026) Table 42. Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales by Region (2021-2026) & (US$ Million) Table 43. Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales Market Share in Value by Region (2021-2026) Table 44. Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales (W Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 45. Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales by Region (2027-2032) & (W Tons) Table 46. Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales Market Share in Volume by Region (2027-2032) Table 47. Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales by Region (2027-2032) & (US$ Million) Table 48. Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales Market Share in Value by Region (2027-2032) Table 49. Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales (W Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2027-2032) Table 50. Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales by Application (2021-2026) & (W Tons) Table 52. Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales Market Share in Volume by Application (2021-2026) Table 53. Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales by Application (2021-2026) & (US$ Million) Table 54. Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales Market Share in Value by Application (2021-2026) Table 55. Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Price by Application (2021-2026) & (US$/Ton) Table 56. Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales by Application (2027-2032) & (W Tons) Table 57. Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales Market Share in Volume by Application (2027-2032) Table 58. Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales by Application (2027-2032) & (US$ Million) Table 59. Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales Market Share in Value by Application (2027-2032) Table 60. Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Price by Application (2027-2032) & (US$/Ton) Table 61. North America Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales by Application (2021-2026) & (W Tons) Table 62. North America Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales by Application (2021-2026) & (W Tons) Table 64. Europe Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales by Application (2021-2026) & (W Tons) Table 66. Asia-Pacific Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales by Application (2021-2026) & (W Tons) Table 68. Latin America Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales by Application (2021-2026) & (W Tons) Table 70. Middle East and Africa Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales by Application (2021-2026) & (US$ Million) Table 71. Novartis Company Information Table 72. Novartis Business Overview Table 73. Novartis Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales (W Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 74. Novartis Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Product Portfolio Table 75. Novartis Recent Development Table 76. Roche Company Information Table 77. Roche Business Overview Table 78. Roche Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales (W Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 79. Roche Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Product Portfolio Table 80. Roche Recent Development Table 81. Bayer Healthcare Company Information Table 82. Bayer Healthcare Business Overview Table 83. Bayer Healthcare Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales (W Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 84. Bayer Healthcare Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Product Portfolio Table 85. Bayer Healthcare Recent Development Table 86. Regeneron Pharmaceuticals Company Information Table 87. Regeneron Pharmaceuticals Business Overview Table 88. Regeneron Pharmaceuticals Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales (W Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 89. Regeneron Pharmaceuticals Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Product Portfolio Table 90. Regeneron Pharmaceuticals Recent Development Table 91. Neurotech Pharmaceuticals Company Information Table 92. Neurotech Pharmaceuticals Business Overview Table 93. Neurotech Pharmaceuticals Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales (W Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 94. Neurotech Pharmaceuticals Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Product Portfolio Table 95. Neurotech Pharmaceuticals Recent Development Table 96. Allergan Company Information Table 97. Allergan Business Overview Table 98. Allergan Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales (W Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 99. Allergan Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Product Portfolio Table 100. Allergan Recent Development Table 101. North America Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size Growth Rate (CAGR) by Country (W Tons): 2021 VS 2025 VS 2032 Table 102. North America Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales by Country (2021-2026) & (W Tons) Table 103. North America Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales Market Share by Country (2021-2026) Table 104. North America Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales Forecast by Country (2027-2032) & (W Tons) Table 105. North America Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales Market Share Forecast by Country (2027-2032) Table 106. North America Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 107. North America Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size by Country (2021-2026) & (US$ Million) Table 108. North America Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Share by Country (2021-2026) Table 109. North America Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 110. North America Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Share Forecast by Country (2027-2032) Table 111. Europe Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size Growth Rate (CAGR) by Country (W Tons): 2021 VS 2025 VS 2032 Table 112. Europe Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales by Country (2021-2026) & (W Tons) Table 113. Europe Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales Market Share by Country (2021-2026) Table 114. Europe Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales Forecast by Country (2027-2032) & (W Tons) Table 115. Europe Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales Market Share Forecast by Country (2027-2032) Table 116. Europe Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 117. Europe Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size by Country (2021-2026) & (US$ Million) Table 118. Europe Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Share by Country (2021-2026) Table 119. Europe Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 120. Europe Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Share Forecast by Country (2027-2032) Table 121. Asia-Pacific Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size Growth Rate (CAGR) by Country (W Tons): 2021 VS 2025 VS 2032 Table 122. Asia-Pacific Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales by Country (2021-2026) & (W Tons) Table 123. Asia-Pacific Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales Market Share by Country (2021-2026) Table 124. Asia-Pacific Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales Forecast by Country (2027-2032) & (W Tons) Table 125. Asia-Pacific Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales Market Share Forecast by Country (2027-2032) Table 126. Asia-Pacific Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 127. Asia-Pacific Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size by Country (2021-2026) & (US$ Million) Table 128. Asia-Pacific Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Share by Country (2021-2026) Table 129. Asia-Pacific Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 130. Asia-Pacific Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Share Forecast by Country (2027-2032) Table 131. Latin America Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size Growth Rate (CAGR) by Country (W Tons): 2021 VS 2025 VS 2032 Table 132. Latin America Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales by Country (2021-2026) & (W Tons) Table 133. Latin America Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales Market Share by Country (2021-2026) Table 134. Latin America Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales Forecast by Country (2027-2032) & (W Tons) Table 135. Latin America Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales Market Share Forecast by Country (2027-2032) Table 136. Latin America Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 137. Latin America Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size by Country (2021-2026) & (US$ Million) Table 138. Latin America Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Share by Country (2021-2026) Table 139. Latin America Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 140. Latin America Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Share Forecast by Country (2027-2032) Table 141. Middle East and Africa Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size Growth Rate (CAGR) by Country (W Tons): 2021 VS 2025 VS 2032 Table 142. Middle East and Africa Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales by Country (2021-2026) & (W Tons) Table 143. Middle East and Africa Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales Market Share by Country (2021-2026) Table 144. Middle East and Africa Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales Forecast by Country (2027-2032) & (W Tons) Table 145. Middle East and Africa Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales Market Share Forecast by Country (2027-2032) Table 146. Middle East and Africa Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 147. Middle East and Africa Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size by Country (2021-2026) & (US$ Million) Table 148. Middle East and Africa Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Share by Country (2021-2026) Table 149. Middle East and Africa Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 150. Middle East and Africa Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Share Forecast by Country (2027-2032) Table 151. Key Raw Materials Table 152. Raw Materials Key Suppliers Table 153. Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Distributors List Table 154. Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Customers List Table 155. Research Programs/Design for This Report Table 156. Authors List of This Report Table 157. Secondary Sources Table 158. Primary Sources List of Figures Figure 1. Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Image Figure 2. Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size (2021-2032) & (US$ Million) Figure 4. Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales (2021-2032) & (W Tons) Figure 5. Macular Degeneration Drugs Image Figure 6. Global Macular Degeneration Drugs Sales YoY Growth (2021-2032) & (W Tons) Figure 7. Diabetic Retinopathy Drugs Image Figure 8. Global Diabetic Retinopathy Drugs Sales YoY Growth (2021-2032) & (W Tons) Figure 9. Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Share by Type 2025 VS 2032 Figure 11. North America Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales Market Share in Volume by Type in 2025 Figure 12. North America Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales Market Share in Value by Type in 2025 Figure 13. Europe Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales Market Share in Volume by Type in 2025 Figure 14. Europe Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales Market Share in Value by Type in 2025 Figure 17. Latin America Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. 50-60 Years Old Image Figure 24. Global 50-60 Years Old Sales YoY Growth (2021-2032) & (W Tons) Figure 25. 60-70 Years Old Image Figure 26. Global 60-70 Years Old Sales YoY Growth (2021-2032) & (W Tons) Figure 27. Others Image Figure 28. Global Others Sales YoY Growth (2021-2032) & (W Tons) Figure 29. Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Share by Application 2025 VS 2032 Figure 31. North America Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales Market Share in Volume by Application in 2025 Figure 32. North America Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales Market Share in Value by Application in 2025 Figure 33. Europe Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales Market Share in Volume by Application in 2025 Figure 34. Europe Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales Market Share in Value by Application in 2025 Figure 37. Latin America Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales Market Share in Value by Application in 2025 Figure 41. North America Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales by Country: 2021 VS 2025 VS 2032 (W Tons) Figure 42. North America Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales by Country: 2021 VS 2025 VS 2032 (W Tons) Figure 46. Europe Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales by Country: 2021 VS 2025 VS 2032 (W Tons) Figure 50. Asia-Pacific Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales by Country: 2021 VS 2025 VS 2032 (W Tons) Figure 54. Latin America Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales by Country: 2021 VS 2025 VS 2032 (W Tons) Figure 58. Middle East and Africa Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Macular Degeneration Drugs
  • Diabetic Retinopathy Drugs
Applications
  • 50-60 Years Old
  • 60-70 Years Old
  • Others
Companies covered
  • Novartis
  • Roche
  • Bayer Healthcare
  • Regeneron Pharmaceuticals
  • Neurotech Pharmaceuticals
  • Allergan

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market by Type
  6. 1.3.1 Macular Degeneration Drugs
  7. 1.3.2 Diabetic Retinopathy Drugs
  8. 1.4 Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size by Type
  9. 1.4.1 Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Industry Trends
  2. 2.2 Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Industry Drivers
  3. 2.3 Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Industry Opportunities and Challenges
  4. 2.4 Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Revenue (2021-2026)
  2. 3.2 Global Top Players by Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales (2021-2026)
  3. 3.3 Global Top Players by Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Price (2021-2026)
  4. 3.4 Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Major Company Production Sites & Headquarters
  6. 3.6 Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Company, Product Type & Application
  7. 3.7 Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Tier 1, Tier 2, and Tier 3
4 Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Regional Status and Outlook
  1. 4.1 Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Historic Market Size by Region
  3. 4.2.1 Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Forecasted Market Size by Region
  7. 4.3.1 Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs by Application
  1. 5.1 Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market by Application
  2. 5.1.1 50-60 Years Old
  3. 5.1.2 60-70 Years Old
  4. 5.1.3 Others
  5. 5.2 Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size by Application
  6. 5.2.1 Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Novartis
  2. 6.1.1 Novartis Company Information
  3. 6.1.2 Novartis Business Overview
  4. 6.1.3 Novartis Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Novartis Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Product Portfolio
  6. 6.1.5 Novartis Recent Developments
  7. 6.2 Roche
  8. 6.2.1 Roche Company Information
  9. 6.2.2 Roche Business Overview
  10. 6.2.3 Roche Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Roche Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Product Portfolio
  12. 6.2.5 Roche Recent Developments
  13. 6.3 Bayer Healthcare
  14. 6.3.1 Bayer Healthcare Company Information
  15. 6.3.2 Bayer Healthcare Business Overview
  16. 6.3.3 Bayer Healthcare Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Bayer Healthcare Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Product Portfolio
  18. 6.3.5 Bayer Healthcare Recent Developments
  19. 6.4 Regeneron Pharmaceuticals
  20. 6.4.1 Regeneron Pharmaceuticals Company Information
  21. 6.4.2 Regeneron Pharmaceuticals Business Overview
  22. 6.4.3 Regeneron Pharmaceuticals Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Regeneron Pharmaceuticals Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Product Portfolio
  24. 6.4.5 Regeneron Pharmaceuticals Recent Developments
  25. 6.5 Neurotech Pharmaceuticals
  26. 6.5.1 Neurotech Pharmaceuticals Company Information
  27. 6.5.2 Neurotech Pharmaceuticals Business Overview
  28. 6.5.3 Neurotech Pharmaceuticals Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Neurotech Pharmaceuticals Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Product Portfolio
  30. 6.5.5 Neurotech Pharmaceuticals Recent Developments
  31. 6.6 Allergan
  32. 6.6.1 Allergan Company Information
  33. 6.6.2 Allergan Business Overview
  34. 6.6.3 Allergan Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Allergan Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Product Portfolio
  36. 6.6.5 Allergan Recent Developments
7 North America by Country
  1. 7.1 North America Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales by Country
  2. 7.1.1 North America Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales by Country (2021-2026)
  4. 7.1.3 North America Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales Forecast by Country (2027-2032)
  5. 7.2 North America Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size by Country
  6. 7.2.1 North America Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size by Country (2021-2026)
  8. 7.2.3 North America Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales by Country
  2. 8.1.1 Europe Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales by Country (2021-2026)
  4. 8.1.3 Europe Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size by Country
  6. 8.2.1 Europe Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size by Country (2021-2026)
  8. 8.2.3 Europe Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales by Country
  2. 9.1.1 Asia-Pacific Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size by Country
  6. 9.2.1 Asia-Pacific Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales by Country
  2. 10.1.1 South America Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales by Country (2021-2026)
  4. 10.1.3 South America Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales Forecast by Country (2027-2032)
  5. 10.2 South America Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size by Country
  6. 10.2.1 South America Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size by Country (2021-2026)
  8. 10.2.3 South America Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales by Country
  2. 11.1.1 Middle East and Africa Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size by Country
  6. 11.2.1 Middle East and Africa Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Value Chain Analysis
  2. 12.1.1 Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Production Mode & Process
  7. 12.2 Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Distributors
  10. 12.2.3 Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst